Stefan Kommoss

München Klinik Schwabing — Germany

Medicine · Health Sciences

41h-index7.3kcitations391works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(216), Endometrial and Cervical Cancer Treatments(139), Endometriosis Research and Treatment(42), Cancer Genomics and Diagnostics(30), Uterine Myomas and Treatments(23)

Publications389 total

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
2025Open Access
Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
2025Open Access
Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2025Open Access
COST-UTILITY ANALYSIS OF A MOLECULAR-INTEGRATED-PROFILE FOR WOMEN WITH (HIGH)INTERMEDIATE RISK ENDOMETRIAL CANCER - PORTEC-4A AN INTERNATIONAL, MULTICENTRE, RANDOMISED, PHASE 3 TRIAL
International Journal of Gynecological Cancer·2025
TOXICITY, HEALTH-RELATED-QUALITY-OF-LIFE AND SEXUAL-HEALTH FOLLOWING MOLECULAR-BASED ADJUVANT TREATMENT IN THE INTERNATIONAL RANDOMISED PORTEC-4A TRIAL
International Journal of Gynecological Cancer·2025
Long non-coding RNAs as a biomarker for homologous recombination deficiency and parp inhibitor sensitivity in high-grade serous ovarian cancers
Communications Biology·2025Open Access
1130P Impact of molecular HRD testing on ovarian cancer patient treatment and survival: A nationwide study of 2087 patients
Annals of Oncology·2025
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer
Cancer & Metabolism·2025· 4 citedOpen Access
5008 PORTEC-4a; an international randomised trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
Radiotherapy and Oncology·2025· 1 cited
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer
2025Open Access
Supplementary Data from ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer
2025Open Access
Data from ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer
2025Open Access
page 1 of 20Next →

Frequent Co-authors

David G. Huntsman(24), Andreas du Bois(16), Friedrich Kommoss(16), Annette Staebler(14), C. Blake Gilks(14), Aline Talhouk(13), Michael S. Anglesio(12), Jessica N. McAlpine(11), Martin Köbel(11), Janine Senz(11), Samuel Leung(10), Philipp Harter(10), Sven� Mahner(9), Sara Y. Brucker(9), F. Kommoss(8), Winnie Yang(8), C. Blake Gilks(8), Jacobus Pfisterer(8), Anthony N. Karnezis(7), Amy Lum(7)